+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

From
Gastric Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Gastric Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Immuno-Oncology Drugs Global Market Report 2024 - Product Thumbnail Image

Immuno-Oncology Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Bone Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Bone Cancer Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Esophageal Cancer Global Market Report 2024 - Product Thumbnail Image

Esophageal Cancer Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Laryngeal Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Laryngeal Cancer Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Desmoid Tumors Global Market Report 2024 - Product Thumbnail Image

Desmoid Tumors Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Nasopharyngeal Carcinoma Treatment Global Market Report 2024 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Drugs for Immunotherapy Global Market Report 2024 - Product Thumbnail Image

Drugs for Immunotherapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Global Market Report 2024 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Sarcoma Drugs Global Market Report 2024 - Product Thumbnail Image

Sarcoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more